Advanced Life Sciences Holdings, Inc. (NASDAQ: ADLS), a biopharmaceutical company, is focused discovering, developing, and commercializing novel drugs in the therapeutic areas of respiratory diseases, infection, and cancer. Cethromycin, the Company’s lead candidate, is a novel NDA-stage once-a-day oral antibiotic designed to treat respiratory tract infections, such as pneumonia. For further information, visit the Company’s web site at www.advancedlifesciences.com.
- 17 years ago
QualityStocks
Advanced Life Sciences Holdings, Inc. (NASDAQ: ADLS)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Advances The Dream Bowl With Tokenized Autographs, National ESPN+ Broadcast
Datavault AI (NASDAQ: DVLT) announced major advancements for The Dream Bowl, its all-star collegiate football showcase…
-
From Ghost Mines to Geophysical Clarity: How Fairchild Gold Corp. (TSX.V: FAIR) (OTCQB: FCHDF) Is Reframing Nevada Titan’s Copper-Gold Potential
Disseminated on behalf of Fairchild Gold Corp. (TSX.V: FAIR) (OTCQB: FCHDF) and may include paid…
-
GlobalTech Corp. (GLTK) Closes Acquisition of Moda in Pelle and Is Redefining Intelligent Retail with AI
GlobalTech Corp. announces that the company closed the acquisition of Moda in Pelle (“MIP”) to…